Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 2

2(33.3%)

Phase 1

2(33.3%)

Phase 3

1(16.7%)

Phase 4

1(16.7%)

6Total

Phase 2(2)

Phase 1(2)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT01744197Phase 2Completed

Synera Venipuncture Pain

Role: collaborator

NCT01623583Phase 4Terminated

Effect of Including Synera® in Discussions on Dialysis Access Conversion in Patients With Needle Phobias

Role: collaborator

NCT01654302Phase 1Completed

Efficacy and Safety of Synera in Osteoarthritis Pain

Role: collaborator

NCT01688518Phase 1Completed

Evaluation of the Depth and Duration of Anesthesia From Heated Lidocaine/Tetracaine (Synera®) Patches Compared With 5% Lidocaine (Lidoderm®) Patches Applied to Healthy Adult Volunteers

Role: collaborator

NCT01579890Unknown

Compassionate Use of Pennsaid Topical Lotion (Diclofenac) in Osteo or Rheumatoid Arthritis

Role: collaborator

NCT01544283Phase 2Unknown

Pain Patch Versus Injections in the Treatment of Pain Associated With Shoulder Impingement Syndrome

Role: collaborator

NCT00108992Phase 3Completed

Efficacy and Safety of Topical Diclofenac Combined With Oral Diclofenac in the Treatment of Knee Osteoarthritis

Role: lead

All 7 trials loaded